Home > Insider Trading > Filing (0001179110-11-009714)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1316175	Anthera Pharmaceuticals Inc	ANTH	Pharmaceutical Preparations (2834)	201852016

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1098349	E Alan Salzman	1001 Bayhill Drive, Suite 300 San Bruno CA 94066	No	No	Yes	No
1114993	Vantagepoint Venture Partners Iv Lp	1001 Bayhill Drive, Suite 300 San Bruno CA 94066	No	No	Yes	No
1129585	Vantagepoint Venture Partners Iv Q Lp	1001 Bayhill Drive, Suite 300 San Bruno CA 94066	No	No	Yes	No
1256847	Vantagepoint Venture Associates Iv Llc	1001 Bayhill Drive, Suite 300 San Bruno CA 94066	No	No	Yes	No
1267585	Vantagepoint Venture Partners Iv Principals Fund Lp	1001 Bayhill Drive, Suite 300 San Bruno CA 94066	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2011-06-13	1,178	$8.80	4,839,645	No	4	S	Direct
Common Stock	Disposition	2011-06-13	118	$8.80	484,496	No	4	S	Direct
Common Stock	Disposition	2011-06-13	4	$8.80	17,624	No	4	S	Direct
Common Stock	Disposition	2011-06-14	634	$8.81	4,839,011	No	4	S	Direct
Common Stock	Disposition	2011-06-14	63	$8.81	484,433	No	4	S	Direct
Common Stock	Disposition	2011-06-14	2	$8.81	17,621	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The General Partner of VantagePoint Venture Partners IV (Q), L.P., VantagePoint Venture Partners IV, L.P., and VantagePoint Venture Partners IV Principals Fund, L.P. is VantagePoint Venture Associates IV, L.L.C. Alan E. Salzman is a managing member of the General Partner and may be deemed to have voting and investment power with respect to the shares or warrants held by these entities. Mr. Salzman disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The address for these entities and Mr. Salzman is 1001 Bayhill Drive, Suite 300, San Bruno, CA 94066.
By: VantagePoint Venture Partners IV (Q), L.P.
By: VantagePoint Venture Partners IV, L.P.
By: VantagePoint Venture Partners IV Principals Fund, L.P.
The Reporting Persons undertake to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Shares were sold at prices between $8.75 and $8.82 per share (rounded to the nearest $.01)